Verge C F, Donaghue K C, Williams P F, Cowell C T, Silink M
Ray Williams Institute of Paediatric Endocrinology, Royal Alexandra Hospital for Children, Sydney, Australia.
Acta Paediatr. 1994 Jul;83(7):786-8. doi: 10.1111/j.1651-2227.1994.tb13142.x.
We report the case of a 13-year-old boy with SHORT syndrome, including lipoatrophy and insulin resistance, who developed diabetes mellitus while receiving growth hormone therapy. The diabetes persisted after cessation of exogenous growth hormone but oral hypoglycaemic therapy was successful and could be discontinued eight months later.
我们报告了一例患有SHORT综合征（包括脂肪萎缩和胰岛素抵抗）的13岁男孩，他在接受生长激素治疗期间患上了糖尿病。停用外源性生长激素后，糖尿病仍持续存在，但口服降糖治疗取得成功，八个月后可停药。
